Myxedema Coma.

Atif Munir

Author(s)

Atif Munir Diabetes and Endocrinology, University Hospital of Hartlepool, UK

Abstract

Myxedema may be the first presentation of patients with undiagnosed hypothyroidism. Definitive management is with thyroid hormone but supportive measures, identification and treatment of precipitating factors in an appropriately safe environment are vital. There is no consensus about preferred thyroid hormone regimen. Corticosteroid therapy is given until adrenal insufficiency has been excluded. We present here a case of seventy-four years old woman of myxodema coma

Publication Details

Page(s) 119-120

DOI DOI not available

Published Journal: Journal of Ayub Medical College, Volume: 30, Issue: 1, Year: 2018

Request the full text from PASTIC

Keywords

NULLL

References

ReinhardtW,MannK,,1997,Incidence, clinical picture, and treatment of hypothyroid coma: results of a survey,Med Klin,92,521-4

,1975,Ventilatory control in myxedema and hypothyroidism,N Engl J Med,292,662-5

KleinI.,,1990,Thyroid hormone and the cardiovascular system,Am J Med,88,631-7

MacKerrowSD,OsbornLA,LevyH,EatonRP,EconomouP,,1992,Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine,Ann Intern Med,117,1014-5

ArlotS,DebusscheX,LalauJD,MesmacqueA,TolaniM,QuichaudJ,,1991,Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment,Intensive Care Med,17,16-8